Guidance

Antiviral resistance testing in the management of hepatitis C

PHE HCV Resistance Group information on the use of hepatitis C virus resistance testing in clinical practice.

From:
Public Health England
Published
7 December 2018

This publication was withdrawn on

This information is now available at .

Documents

Ref: PHE publications gateway number: 2018603

PDF, 1.16 MB, 48 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This working document, written by Public Health England鈥檚 (PHE) Hepatitis C Virus Resistance Group, aims to support clinicians treating people with HCV, where the issue of resistance may be a factor in clinical decision-making.

Updates to this page

Published 7 December 2018

Sign up for emails or print this page

Related content